New vaccine vs. rotavirus has promise
A new vaccine against rotavirus, the diarrheal infection that kills millions of children worldwide, does not appear to raise the risk of serious bowel blockages that caused a previous vaccine to be pulled from the market five years ago, doctors reported
Johnson &amp; Johnson will delay by five months the release of a study comparing its Cypher heart device with Boston Scientific Corp.'s Taxus, the first large-scale comparison of the only two drug-coated stents on the market.